Forgone care and financial burden due to out-of-pocket payments within the German health care system

Health Economics Review

Volumn 4, Issue 1, 2014, Pages

  Bremer, Patrick ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Equity; Forgone care; Germany; Out of pocket payments; Sample selection model

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DEPENDENT VARIABLE; ECONOMIC ASPECT; FINANCIAL MANAGEMENT; HEALTH CARE; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE SYSTEM; HEALTH STATUS; HUMAN; INDEPENDENT VARIABLE; LOWEST INCOME GROUP; OUT OF POCKET PAYMENT; PREVALENCE; QUESTIONNAIRE; REGRESSION ANALYSIS; RETIREMENT; SOCIAL STATUS;

EID: 84963876032     PISSN: None     EISSN: 21911991     Source Type: Journal    
DOI: 10.1186/s13561-014-0036-0     Document Type: Article

References (32)

1. Statistisches Bundesamt [https://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/dboowasys921.xwdevkit/xwd_init?gbe.isgbetol/xs_start_neu/&p_aid=3&p_aid=5624967&nummer=322&p_sprache=D&p_indsp=99999999&p_aid=82916889]
2. Beske F, Golbach U: Zuzahlungen im Gesundheitswesen: Grundlagen, internationaler Vergleich und Konzepte für die Gesetzliche Krankenversicherung. Kiel: Schriftenreihe des Fritz Beske Instituts für Gesundheits-System-Forschung; 2009:111.
3. Pfaff AB, Langer B, Mamberer F, Freund F, Kern OA, Pfaff M: Zuzahlungen nach dem GKV-Modernisierungsgesetz (GMG) unter Berücksichtigung von Härtefallregelungen. Augsburg: INEFS-Universität Augsburg, Volkswirtschaftliche Diskussionsreihe; 2003:253.
4. Gruber J: The Role of Consumer Copayments for Health Care: Lessons from the RAND Health Insurance Experiment and Beyond. Washington, DC: Kaiser Family Foundation Report; 2006.
5. Schulenburg JM: Selbstbeteiligungen: Theoretische und empirische Konzepte für die Analyse ihrer Allokations- und Verteilungswirkungen. Tübingen: Schriften zur angewandten Wirtschaftsforschung 1987, 51.
6. Wagstaff A, Van Doorslaer E: Equity in the finance and delivery of health care: Some international comparisons.J of Health Economics 1992, 11:361–387.
7. Baji P, Pavlova M, Gulácsi L, Groot, W: Changes in Equity in Out-of-pocket Payments during the Period of Health Care Reforms: Evidence from Hungary.Int J Equity Health 2012: 11–36.
8. Akazili J, Gyapong J, McIntyre D: Who pays for health in care in Ghana?Int J Equity Health 2011: 10–26.
9. Sambamoorthi U, Shea D, Crystal S: Total and out-of-pocket expenditures for prescription drugs among older persons.Gerontologist 2003, 43:345–359.
10. Klein D, Turvey C, Wallace R: Elders who delay medication because of cost: health insurance, Demographic, health and financial correlates.Gerontologist 2004, 44:779–787.
11. Crystal S, Johnson RW, Harman J, Sambamoorthi U, Kumar R: Out-of-pocket health care costs among older Americans.J Gerontol B Psychol Sci Soc Sci 2000, 55:51–62.
12. Rogowski J, Lillard LA, Kongton R: The financial burden of prescription drug use among older persons.Gerontologist 1997, 37:475–482.
13. Wei WH, Akincigil A, Crystal S, Sambamoorthi U: Gender differences in out-of-pocket prescription drug expenditures among the elderly.Research on Aging 2006, 28:427–453.
14. Holst J: Kostenbeteiligungen für Patienten – Reformansatz ohne Evidenz! Theoretische Betrachtungen und empirische Befunde aus Industrieländern. Berlin: Wissenschaftszentrum Berlin für Sozialforschung (WZB) Discussion Paper; 2008.
15. Litwin H, Sapir E: Forgone health care due to cost among older adults in European countries and in Israel.European J of Ageing 2009, 6:167–176.
16. Piette JD, Heisler M, Wagner TH: Cost-Related Medication Underuse Among Chronically Ill Adults: the Treatments People Forgo, How often, and Who is at Risk.Am J of Public Health 2004, 94:1782–1787.
17. Holst J, Laaser U: Zuzahlungen im Gesundheitswesen: Unsozial, diskriminierend und ineffektiv.Deutsches Ärzteblatt 2003, 51(100):3358–3361.
18. Sozialgesetzbuch Fünftes Buch, Gesetzliche Krankenversicherung (SGB V) § 62, Belastungsgrenze, 2014.
19. Bremer P, Sauerland D, Wübker A: Zuzahlungen im deutschen Gesundheitssystem: Ausmaß, Determinanten und Konsequenzen für die Medikamenteninanspruchnahme. In Gesundheitsmonitor 2013. Edited by Böcken J, Braun B, Repschläger U. Gütersloh: Verlag Bertelsmann Stiftung; 2013:169–187.
20. Schreyögg J, Grabka MM: Copayments for ambulatory care in Germany: a natural experiment using a difference-in-difference approach.Eur J Health Econ 2010, 11:331–341.
21. Winkelmann R: Co-payments for prescription drugs and the demand for doctor visits – Evidence from a natural experiment.Health Econ 2004, 13:1081–1089.
22. Mielck A, Kiess R, von dem Knesebeck O, Stirbu I, Kunst AE: Association between forgone care and household income among the elderly in five Western European countries – analyses based on survey data from the SHARE-study.BMC Health Serv Res 2009, 9:52.
23. Böhm K: Tesch-Römer C. T: Gesundheit und Krankheit im Alter. Beiträge zur Gesundheitsberichterstattung des Bundes. Berlin: Ziese; 2009.
24. Brugiavini A, Croda E, Paccagnella O, Rainato R, Weber G: Generated Income Variables in SHARE release 1, In The Survey of Health Ageing and Retirement in Europe: Methodology. Börsch-Supan A, Jürges H et al. (eds). Mannheim Research Institute for the Economics of Ageing, Mannheim; 2005, 105–113.
25. Grossman M: On the concept of health capital and the demand for health.J Polit Econ 1972, 80:223–255.
26. Van Doorslaer E, Masseria C: Income-Related Inequality in the Use of Medical Care in 21 OECD Countries. Paris: OECD Working Paper No. 14; 2004.
27. Jones A: Applied Econometrics for Health Economists: A Practical Guide. London: Radcliffe Medical Press; 2007.
28. O’ Donnell O, van Doorslaer E, Wagstaff A, Lindelow M: Analyzing Health Equity Using Household Survey Data. A Guide to Techniques and Their Implementation. Washington, D.C: The World Bank Institute; 2008.
29. Corrieri S, Heider D, Matschinger H, Lehnert T, Raum E, König HH: Income-, education- and gender-related inequalities in out-of-pocket health-care payments for 65+ patients – a systematic review.Int J Equity Health 2010: 9–20.
30. Tamblyn R, Laprise R, Hanley J, Abrahamowicz M, Scott S, Mayo NE, Hurley J, Grad R, Latimer E, Perrault R, McLeod P, Huang AS, Larochelle P, Mallet L: Adverse Events Associated with Prescription Drug Cost-Sharing Among Poor and Elderly Persons.JAMA 2001, 285:421–429.
31. Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S: Payment Restrictions for Prescription Drugs under Medicaid.N Engl J Med 1987, 27:550–556.
32. Richardson J: The Effects of Consumer Co-payments in Medical Care. Melbourne: National Health Strategy Background Paper No. 5; 1991.